<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03328169</url>
  </required_header>
  <id_info>
    <org_study_id>121635</org_study_id>
    <nct_id>NCT03328169</nct_id>
  </id_info>
  <brief_title>Comparative Effectiveness Feasibility Trial for Insomnia Among Breast Cancer Survivors</brief_title>
  <official_title>Comparative Effectiveness Feasibility Trial for Insomnia Among Breast Cancer Survivors</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>George Washington University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>George Washington University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Women with breast cancer who report insomnia that started or worsened during breast cancer
      diagnosis and treatment will be enrolled in a group behavioral trial to one of two arms
      testing cognitive behavioral therapy for insomnia against a mindfulness-based therapy.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The investigators are recruiting breast cancer survivors with stage I-III or Eastern
      Cooperative Oncology Group 0-1 breast cancer to enroll in a group-delivered behavioral trial
      for insomnia. The investigators are comparing mindfulness-based therapies delivered in an
      alternative medicine context to cognitive behavioral therapy for insomnia. The intervention
      is 9 weeks, for two hours weekly.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">April 15, 2017</start_date>
  <completion_date type="Actual">June 28, 2018</completion_date>
  <primary_completion_date type="Actual">June 28, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in Insomnia</measure>
    <time_frame>Nine weeks</time_frame>
    <description>Measured using the Insomnia Severity Index (Scale 0-28; higher scores are worse, with 15+ indicating clinical insomnia)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in Insomnia</measure>
    <time_frame>Nine weeks</time_frame>
    <description>Measured using the Pittsburgh Sleep Quality Index (Scale 0-21; higher scores are worse)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in cognitive function</measure>
    <time_frame>Nine weeks</time_frame>
    <description>Measured via the FACT-Cog (Scale 0-132; higher is better)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in cognitive function</measure>
    <time_frame>Nine weeks</time_frame>
    <description>Measured via the Montreal Cognitive Assessment (MOCA)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Fatigue</measure>
    <time_frame>Nine weeks</time_frame>
    <description>Patient-Reported Outcomes Measurement Information System (PROMIS) Fatigue (Scale 8-40; higher is worse)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Insomnia</measure>
    <time_frame>Nine weeks</time_frame>
    <description>Measured using an actigraph</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">26</enrollment>
  <condition>Breast Cancer Female</condition>
  <condition>Insomnia</condition>
  <arm_group>
    <arm_group_label>CBT-I</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Cognitive Behavioral Therapy for Insomnia</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Mindfulness</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Mindfulness-Based Therapy</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Mindfulness-Based Therapy</intervention_name>
    <description>Participants are taught relaxation and mindfulness techniques to practice. They also learn about various alternative medicine modalities to which they can apply mindfulness with the target of reducing insomnia. The group meets weekly for 2 hours for a duration of 9 weeks.</description>
    <arm_group_label>Mindfulness</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Cognitive Behavioral Therapy for Insomnia</intervention_name>
    <description>A licensed psychologist is delivering Cognitive Behavioral Therapy for Insomnia to women for 90-120 minutes weekly for nine weeks. The Cognitive Behavioral Therapy for Insomnia protocol is well documented in published literature.</description>
    <arm_group_label>CBT-I</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  American Joint Committee on Cancer (AJCC) Stage I-III or Eastern Cooperative Oncology
             Group (ECOG) 0-1 breast cancer

          -  completed active treatment (surgery, radiation, chemotherapy) at least three months
             prior

          -  within 5 years of treatment or still on adjuvant therapy

          -  Completes informed consent to participate

        Exclusion Criteria:

          -  sleep apnea or restless leg syndrome

          -  practicing mindfulness techniques &gt;1/wk
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>GW Center for Integrative Medicine</name>
      <address>
        <city>Washington</city>
        <state>District of Columbia</state>
        <zip>20052</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2018</verification_date>
  <study_first_submitted>October 24, 2017</study_first_submitted>
  <study_first_submitted_qc>October 27, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">November 1, 2017</study_first_posted>
  <last_update_submitted>August 14, 2018</last_update_submitted>
  <last_update_submitted_qc>August 14, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">August 15, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>George Washington University</investigator_affiliation>
    <investigator_full_name>Hannah Arem</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Breast Neoplasms</mesh_term>
    <mesh_term>Sleep Initiation and Maintenance Disorders</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

